
What happened
Merck announced a research collaboration with Isomorphic Labs to discover small-molecule candidates against an undisclosed oncology target. Isomorphic will run in silico predictions and deliver molecular designs using its IsoDDE engine on Merck's proprietary data; Merck takes responsibility for preclinical and clinical development, manufacturing and commercialization.
Why it matters
Isomorphic is eligible for research, development, regulatory and commercial milestone payments and tiered royalties on net sales, and can co-fund development for elevated royalties — amounts were not disclosed, so the deal's value remains unquantified.
WHO IT HITSThis deal matters to Merck's oncology research teams and Isomorphic's drug-design scientists, who will apply the IsoDDE engine to Merck's proprietary data sets. It also affects business development teams at other pharma companies weighing similar AI drug-discovery partnerships, though the financial terms remain undisclosed.
Summaries like this, every morning.
The Merck deal places Isomorphic Labs' IsoDDE engine at the front of a pharma giant's oncology pipeline, with Isomorphic generating molecular designs from Merck's proprietary data before handing candidates off for preclinical and clinical work. That division of labor — AI design on one side, development and commercialization on the other — mirrors the structure of Isomorphic's earlier partnerships, including its 2024 work with Eli Lilly and Novartis and a January 2026 collaboration with Janssen spanning multiple targets and drug modalities.
The timing is notable: two days before the Merck announcement, Isomorphic raised USD 5 billion in a Series C co-led by Greenoaks and Sequoia Capital, with continued backing from Alphabet. The company said it would use the funding to expand IsoDDE and advance both its own and partnered drug candidates, so the Merck collaboration adds another partnered program to that portfolio. Because the financial terms of the Merck deal were not disclosed, it is not possible to gauge its relative size against those other agreements.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
At Open Source Summit Europe 2026 in Prague, a Texas Instruments-moderated panel said embedded engineers are b…

A Seeking Alpha analyst upgraded Broadcom (AVGO) to Strong Buy, arguing it should lead investors out of the cu…

Dell shares are up 165.55% year to date but 26.68% lower over the past month, at $330.75 versus a 52-week high…

Intel is promoting laptops with its Core Ultra chips as AI PCs for the holidays, spotlighting on-device featur…

On the Nov. 19 earnings call, CEO John Furner said U.S

On a Q3 2027 earnings call, CEO John Furner said Walmart is preparing its omnichannel experience for internal…
